Provided by Tiger Trade Technology Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

77.58
-0.9400-1.20%
Volume:30.44K
Turnover:2.37M
Market Cap:6.05B
PE:78.36
High:78.42
Open:77.66
Low:77.20
Close:78.52
52wk High:82.94
52wk Low:35.20
Shares:78.02M
Float Shares:39.94M
Volume Ratio:0.76
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9900
EPS(LYR):0.7500
ROE:14.04%
ROA:8.05%
PB:9.25
PE(LYR):103.44

Loading ...

Kiniksa publishes 2025 annual report

Reuters
·
May 09

Kiniksa CMO John F. Paolini disposes 58,424 shares for $3.15 million

Reuters
·
May 06

Kiniksa Pharmaceuticals CSO Resigns and Shifts to Advisor

TIPRANKS
·
May 02

Kiniksa Chief Strategy Officer Eben Tessari resigns to pursue new role

Reuters
·
May 02

Kiniksa CEO Sanj K Patel disposes of 486,339 shares for $25.23 million

Reuters
·
May 01

Kiniksa Pharmaceuticals’ Mine Safety Disclosure: No Incidents Reported but Transparency Gaps Remain for Investors

TIPRANKS
·
Apr 30

Kiniksa director Barry Quart sells 13,099 shares for $656,812.9

Reuters
·
Apr 30

Kiniksa Pharmaceuticals Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Apr 30

Canaccord Genuity Reaffirms Their Buy Rating on Kiniksa Pharmaceuticals (KNSA)

TIPRANKS
·
Apr 29

Kiniksa Pharmaceuticals International Plc : Wells Fargo Raises Target Price to $57 From $53

THOMSON REUTERS
·
Apr 29

Kiniksa Pharmaceuticals Is Maintained at Buy by Jefferies

Dow Jones
·
Apr 29

Kiniksa price target raised to $71 from $58 at Jefferies

TIPRANKS
·
Apr 29

Kiniksa Pharmaceuticals Up Over 20%, on Track for Record High Close -- Data Talk

Dow Jones
·
Apr 29

Wedbush Lifts Price Target on Kiniksa Pharmaceuticals International to $59 From $58, Maintains Outperform Rating

MT Newswires Live
·
Apr 28

Kiniksa rises 16.9%

TIPRANKS
·
Apr 28

Stock Track | Kiniksa Pharmaceuticals Soars 12.74% on Strong Q1 Earnings Beat and Raised Revenue Guidance

Stock Track
·
Apr 28

How Kiniksa’s Shift To Profitability And Higher Revenue At Kiniksa Pharmaceuticals International (KNSA) Has Changed Its Investment Story

Simply Wall St.
·
Apr 28

KNSA Earnings: Kiniksa Pharmaceuticals Stock Surges on Strong Q1 Beats

TIPRANKS
·
Apr 28

Kiniksa publishes corporate presentation on ARCALYST growth in recurrent pericarditis market

Reuters
·
Apr 28

Kiniksa reports Q1 EPS 27c, consensus 16c

TIPRANKS
·
Apr 28